
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9454674
[patent_doc_number] => 08715678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Method for inhibiting the formation of SET1 family core complexes'
[patent_app_type] => utility
[patent_app_number] => 13/415474
[patent_app_country] => US
[patent_app_date] => 2012-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 7618
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415474
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/415474 | Method for inhibiting the formation of SET1 family core complexes | Mar 7, 2012 | Issued |
Array
(
[id] => 8323482
[patent_doc_number] => 20120195889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/372824
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24721
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372824
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372824 | BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS | Feb 13, 2012 | Abandoned |
Array
(
[id] => 8221687
[patent_doc_number] => 20120135891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'METHODS AND DEVICES FOR EARLY DETECTION OF CANCER CELLS AND TYPES THROUGH MICROMECHANICAL INTERACTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/361328
[patent_app_country] => US
[patent_app_date] => 2012-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9999
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361328
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/361328 | METHODS AND DEVICES FOR EARLY DETECTION OF CANCER CELLS AND TYPES THROUGH MICROMECHANICAL INTERACTIONS | Jan 29, 2012 | Abandoned |
Array
(
[id] => 8184196
[patent_doc_number] => 20120114673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/357913
[patent_app_country] => US
[patent_app_date] => 2012-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 79637
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114673.pdf
[firstpage_image] =>[orig_patent_app_number] => 13357913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/357913 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR | Jan 24, 2012 | Abandoned |
Array
(
[id] => 8240921
[patent_doc_number] => 20120149648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 13/352223
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 34485
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352223
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/352223 | Therapeutic peptidomimetic macrocycles | Jan 16, 2012 | Issued |
Array
(
[id] => 9121351
[patent_doc_number] => 20130288273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'Method for Detecting Cancer Cell'
[patent_app_type] => utility
[patent_app_number] => 13/995585
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19960
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995585 | Method for detecting cancer cell | Dec 21, 2011 | Issued |
Array
(
[id] => 8251910
[patent_doc_number] => 20120156232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'CANCER VACCINES AND VACCINATION METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/327125
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15068
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156232.pdf
[firstpage_image] =>[orig_patent_app_number] => 13327125
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/327125 | Cancer vaccines and vaccination methods | Dec 14, 2011 | Issued |
Array
(
[id] => 9099806
[patent_doc_number] => 08563684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-22
[patent_title] => 'Tumor antigen protein SART-3 and tumor antigen peptides thereof'
[patent_app_type] => utility
[patent_app_number] => 13/326304
[patent_app_country] => US
[patent_app_date] => 2011-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17916
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/326304 | Tumor antigen protein SART-3 and tumor antigen peptides thereof | Dec 13, 2011 | Issued |
Array
(
[id] => 8265240
[patent_doc_number] => 20120164656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/323227
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 56540
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323227
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/323227 | Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative Disorders | Dec 11, 2011 | Abandoned |
Array
(
[id] => 8265977
[patent_doc_number] => 20120165403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'METHODS OF INHIBITING THE ACTIVITY OF HSP90 AND/OR ARYL HYDROCARBON RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/316092
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18017
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316092
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/316092 | METHODS OF INHIBITING THE ACTIVITY OF HSP90 AND/OR ARYL HYDROCARBON RECEPTOR | Dec 8, 2011 | Abandoned |
Array
(
[id] => 10919223
[patent_doc_number] => 20140322242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/991091
[patent_app_country] => US
[patent_app_date] => 2011-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 21389
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991091
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991091 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER | Nov 23, 2011 | Abandoned |
Array
(
[id] => 8160228
[patent_doc_number] => 20120101084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Biological Markers Predictive of Anti-Cancer Response to Insulin-Like Growth Factor-1 Receptor Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/282567
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 50335
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101084.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282567
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282567 | Biological Markers Predictive of Anti-Cancer Response to Insulin-Like Growth Factor-1 Receptor Kinase Inhibitors | Oct 26, 2011 | Abandoned |
Array
(
[id] => 8313015
[patent_doc_number] => 20120190046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'DEK as a urine based biomarker for bladder cancer'
[patent_app_type] => utility
[patent_app_number] => 13/317532
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13364
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13317532
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/317532 | DEK as a urine based biomarker for bladder cancer | Oct 19, 2011 | Issued |
Array
(
[id] => 9503270
[patent_doc_number] => 08741582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Detection of a specific DEK isoform as a urine-based biomarker for bladder cancer'
[patent_app_type] => utility
[patent_app_number] => 13/317531
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19313
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13317531
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/317531 | Detection of a specific DEK isoform as a urine-based biomarker for bladder cancer | Oct 19, 2011 | Issued |
Array
(
[id] => 9232808
[patent_doc_number] => 08598112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells'
[patent_app_type] => utility
[patent_app_number] => 13/276237
[patent_app_country] => US
[patent_app_date] => 2011-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 20949
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276237
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/276237 | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells | Oct 17, 2011 | Issued |
Array
(
[id] => 8989774
[patent_doc_number] => 20130217055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'METHOD FOR PREDICTING TYROSINE KINASE INHIBITOR (TKI) RESISTANCE IN PATIENTS SUFFERING FROM CHRONIC MYELOGENOUS LEUKEMIA (CML)'
[patent_app_type] => utility
[patent_app_number] => 13/879046
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9429
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879046
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879046 | METHOD FOR PREDICTING TYROSINE KINASE INHIBITOR (TKI) RESISTANCE IN PATIENTS SUFFERING FROM CHRONIC MYELOGENOUS LEUKEMIA (CML) | Oct 16, 2011 | Abandoned |
Array
(
[id] => 11915435
[patent_doc_number] => 09783613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'IgE anti-HMW-MAA antibody'
[patent_app_type] => utility
[patent_app_number] => 14/348997
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 33
[patent_no_of_words] => 19190
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348997
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348997 | IgE anti-HMW-MAA antibody | Oct 3, 2011 | Issued |
Array
(
[id] => 8744865
[patent_doc_number] => 20130084582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'SEROLOGICAL MARKERS FOR DETECTING COLORECTAL CANCER AND THEIR APPLICATION FOR INHIBITING COLORECTAL CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/252976
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4554
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252976 | SEROLOGICAL MARKERS FOR DETECTING COLORECTAL CANCER AND THEIR APPLICATION FOR INHIBITING COLORECTAL CANCER CELLS | Oct 3, 2011 | Abandoned |
Array
(
[id] => 9823340
[patent_doc_number] => 08932824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Method of detecting cancer using delta-catenin'
[patent_app_type] => utility
[patent_app_number] => 13/251481
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10106
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/251481 | Method of detecting cancer using delta-catenin | Oct 2, 2011 | Issued |
Array
(
[id] => 8744870
[patent_doc_number] => 20130084587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'Levels of cytokeratins in blood and body fluids as biomarkers for cancer screening, diagnosis and treatment monitoring'
[patent_app_type] => utility
[patent_app_number] => 13/251228
[patent_app_country] => US
[patent_app_date] => 2011-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1248
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251228
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/251228 | Levels of cytokeratins in blood and body fluids as biomarkers for cancer screening, diagnosis and treatment monitoring | Sep 30, 2011 | Abandoned |